Literature DB >> 25770901

Pre-operative electrodiagnostic testing predicts time to resolution of symptoms after carpal tunnel release.

J R Fowler1, M Munsch2, Y Huang2, W C Hagberg2, J E Imbriglia2.   

Abstract

UNLABELLED: The purpose of this study was to determine if nerve conduction studies predict time to resolution of symptoms after carpal tunnel release. A total of 56 patients undergoing open carpal tunnel release were prospectively enrolled. Pre-operative presence of nocturnal symptoms and daytime numbness/tingling were documented. Pre-operative nerve conduction studies were reviewed and classified as mild, moderate, or severe. After open carpal tunnel release, patients were contacted by phone within 48 hours, at 1 week, and then at 2-week intervals for up to 9 months or until both nocturnal and daytime symptoms had resolved. This study found that patients with mild or moderate carpal tunnel syndrome experience a faster time to resolution of daytime numbness and tingling when compared with patients with severe carpal tunnel syndrome. Nocturnal symptoms resolved quickly in both groups. The results of this study are in contrast to previous studies that found little to no value of nerve conduction studies in predicting post-operative functional and subjective outcomes. LEVEL OF EVIDENCE: IV.
© The Author(s) 2015.

Entities:  

Keywords:  Carpal tunnel syndrome; electrodiagnostic testing; nerve conduction testing

Mesh:

Year:  2015        PMID: 25770901     DOI: 10.1177/1753193415576248

Source DB:  PubMed          Journal:  J Hand Surg Eur Vol        ISSN: 0266-7681


  11 in total

1.  Variation in Nonsurgical Services for Carpal Tunnel Syndrome Across a Large Integrated Health Care System.

Authors:  Erika D Sears; Esther L Meerwijk; Eric M Schmidt; Eve A Kerr; Kevin C Chung; Robin N Kamal; Alex H S Harris
Journal:  J Hand Surg Am       Date:  2018-12-20       Impact factor: 2.230

2.  Independent Variables Affecting Outcome of Carpal Tunnel Release Surgery.

Authors:  Jacqueline D Watchmaker; Greg P Watchmaker
Journal:  Hand (N Y)       Date:  2017-04-01

3.  Ultrasonography Findings in Severe Carpal Tunnel Syndrome.

Authors:  Gideon Nkrumah; Alan R Blackburn; Robert J Goitz; John R Fowler
Journal:  Hand (N Y)       Date:  2018-07-20

4.  Prognostic Variables for Patient Return-to-Work Interval Following Carpal Tunnel Release in a Workers' Compensation Population.

Authors:  Jenniefer Y Kho; Michael P Gaspar; Patrick M Kane; Sidney M Jacoby; Eon K Shin
Journal:  Hand (N Y)       Date:  2016-07-28

5.  Motor Examination in the Diagnosis of Carpal Tunnel Syndrome.

Authors:  Mithun Neral; Joseph E Imbriglia; Lois Carlson; Ronit Wollstein
Journal:  J Hand Microsurg       Date:  2017-05-25

6.  Outcomes of Mini-Open Carpal Tunnel Release in Patients With Unrecordable Preoperative Nerve Conduction Potentials at a Minimum of 5 Years.

Authors:  Dafang Zhang; Peter Ostergaard; Charles Cefalu; Matthew Hall; Brandon E Earp; Philip Blazar
Journal:  Hand (N Y)       Date:  2019-06-22

7.  Outcome of carpal tunnel decompression with pre-surgical diagnosis determined on general practitioner assessment and nerve conduction study.

Authors:  Raphael Matsis; Justin Chou; Nicholas Clode
Journal:  J Clin Orthop Trauma       Date:  2020-09-06

8.  The Association Between Electrodiagnostic Severity and Treatment Recommendations for Carpal Tunnel Syndrome.

Authors:  Yu-Ting Lu; Amrit K Deol; Erika D Sears
Journal:  J Hand Surg Am       Date:  2020-10-31       Impact factor: 2.230

9.  A Comparison of Changes in Median Nerve Cross-sectional Area Between Endoscopic and Mini-Open Carpal Tunnel Release.

Authors:  William R Smith; David C Hirsch; David O Osei-Hwedieh; Robert J Goitz; John Fowler
Journal:  J Hand Surg Glob Online       Date:  2019-10-31

10.  Electrodiagnostic, Sonographic, and Clinical Features of Carpal Tunnel Syndrome with Bifid Median Nerve.

Authors:  Dougho Park; Byung Hee Kim; Sang-Eok Lee; Dong Young Kim; Yoon Sik Eom; Jae Man Cho; Joong Won Yang; Mansu Kim; Heum Dai Kwon
Journal:  J Pain Res       Date:  2021-05-18       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.